Current SPORE projects and leaders
January 15, 2020 | Leigh MacMillan
GI SPORE
Colorectal stem cells as a therapeutic target
Robert Coffey, MD
Ken Lau, PhD
Overcoming resistance to EGFR-targeted therapies
Jordan Berlin, MD
Charles Manning, PhD
MYC inhibitor drug development
Daniel Beauchamp, MD Stephen Fesik, PhD
William Tansey, PhD
Breast SPORE
Overcoming resistance to endocrine therapies
Brent Rexer, MD, PhD
Carlos Arteaga, MD
Improving outcomes for triple-negative breast cancer
Vandana Abramson, MD
Jennifer Pietenpol, PhD
Targeting the DNA damage response in breast cancer
Vandana Abramson, MD
David Cortez, PhD
Enhancing immunotherapy responses in breast cancer
Ingrid Mayer, MD, MSCI
Justin Balko, PharmD, PhD